Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden.

Although there were numerical differences in the level of END, ADMA, TSP, ENG, and ANG across quartiles of plaque burden (Table 3 ), differences were marginal and did not achieve significance in unadjusted analyses ( P ≥ 0.18 for all comparisons).

also in 1,397 other papers